E-LIB Suche - Ergebnisse für: Miura, Yuji

1

Effectiveness and safety of primary prophylaxis of G-CSF du..:

Kimura, Shoji ; Shigeta, Keisuke ; Tamura, Shingo...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 559-563 , 2024

Link: https://doi.org/10.1007/..

2

Phase 3 THOR Japanese subgroup analysis: erdafitinib in adv..:

Matsubara, Nobuaki ; Miura, Yuji ; Nishiyama, Hiroyuki...
International Journal of Clinical Oncology. , 2024

Link: https://doi.org/10.1007/..

3

UPDATED EFFICACY AND SAFETY OF ORAL ERDAFITINIB IN PATIENTS..:

Catto, James WF ; Hussain, Syed A ; Tran, Ben...
Urologic Oncology: Seminars and Original Investigations. 42 (2024) - p. S53 , 2024

Link: https://doi.org/10.1016/..

4

Optimal timing of prophylactic pegylated G-CSF after chemot..:

Ozaki, Yukinori ; Yokoe, Takamichi ; Yoshinami, Tetsuhiro...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 551-558 , 2024

Link: https://doi.org/10.1007/..

5

Effectiveness and safety of primary prophylaxis of granuloc..:

Uchino, Keita ; Tamura, Shingo ; Kimura, Shoji...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 545-550 , 2024

Link: https://doi.org/10.1007/..

6

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Nozawa, Kazuki ; Ozaki, Yukinori ; Yoshinami, Tetsuhiro...
International Journal of Clinical Oncology. 29 (2024) 8 - p. 1074-1080 , 2024

Link: https://doi.org/10.1007/..

7

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Ichihara, Eiki ; Ochi, Nobuaki ; Makimoto, Go...
International Journal of Clinical Oncology. 29 (2024) 4 - p. 355-362 , 2024

Link: https://doi.org/10.1007/..

8

Prognostic significance of inflammatory markers in patients..:

Nakayama, Takayuki ; Takeshita, Hideki ; Kagawa, Makoto...
International Journal of Clinical Oncology. , 2024

Link: https://doi.org/10.1007/..

9

Therapeutic use of granulocyte colony-stimulating factor (G..:

Tsuchihashi, Kenji ; Ito, Mamoru ; Okumura, Yuta...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 700-705 , 2024

Link: https://doi.org/10.1007/..

10

Comparison between a single dose of PEG G-CSF and multiple ..:

Yoshinami, Tetsuhiro ; Nozawa, Kazuki ; Yokoe, Takamichi...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 681-688 , 2024

Link: https://doi.org/10.1007/..

11

Effectiveness of G-CSF in chemotherapy for digestive system..:

Ito, Mamoru ; Okumura, Yuta ; Nio, Kenta...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 689-699 , 2024

Link: https://doi.org/10.1007/..

12

Potential protumor function of CD74 in clear cell renal cel..:

Ezaki, Ayano ; Yano, Hiromu ; Pan, Cheng...
Human Cell. , 2024

Link: https://doi.org/10.1007/..

13

Primary prophylaxis with G-CSF for patients with non-round ..:

Hirose, Takeshi ; Ito, Mamoru ; Tsuchihashi, Kenji...
International Journal of Clinical Oncology. 29 (2024) 8 - p. 1067-1073 , 2024

Link: https://doi.org/10.1007/..

14

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Hirose, Takeshi ; Ito, Mamoru ; Tsuchihashi, Kenji...
International Journal of Clinical Oncology. 29 (2024) 8 - p. 1081-1087 , 2024

Link: https://doi.org/10.1007/..

15

Complete response of metastatic papillary renal cell carcin..:

Hayashida, Michikata ; Miura, Yuji ; Yamaguchi, Takeshi...
IJU Case Reports. 6 (2023) 6 - p. 419-423 , 2023

Link: https://doi.org/10.1002/..